1887

Abstract

Recent evidence of a protective immune response to the flavivirus non-structural protein, NS1, has suggested its incorporation into possible recombinant vaccines. The region of the 17D yellow fever virus (YFV) genome encoding the C terminus of envelope glycoprotein and extending to the N terminus of non-structural protein NS3 (NSl-NS2a-NS2b; nucleotides 2030 to 4940) was expressed in vaccinia virus and physical and immunogenic properties of the NS1 moiety were studied. Recombinant NS1 protein, and native YFV NS1, was detected at the surface of infected cells by immunofluorescence and by immune cytolysis after treatment with anti-NSl antibody and complement. NS1 was also detected in the extracellular medium as a secreted form. Recombinant NS1 was immunoprecipi- tated as a single protein of approximately the same size as native 17D YFV NS1. Unboiled, both recombinant and native NS1 formed polymers of high . Immunization of mice with this recombinant vaccinia virus stimulated production of non-neutralizing, complement-fixing cytolytic antibody and conferred partial protection against lethal intracerebral inoculation of mice with live 17D YFV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-8-1697
1990-08-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/8/JV0710081697.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-8-1697&mimeType=html&fmt=ahah

References

  1. Bray M., Zhao B., Markoff L., Eckels K. H., Chanock R. M., Lai C.-J. 1989; Mice immunized with recombinant vaccinia virus expressing dengue 4 structural proteins with or without nonstructural protein NS1 are protected against fatal dengue encephalitis. Journal of Virology 63:2853–2856
    [Google Scholar]
  2. Bukowski J. F., Kurane I., Lai C.-J., Bray M., Falgout B., Ennis F. A. 1989; Dengue virus-specific cross-reactive CD8+ human cytotoxic T lympocytes. Journal of Virology 63:5086–5091
    [Google Scholar]
  3. Cane P. A., Gould E. A. 1988; Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment. Journal of General Virology 69:1241–1246
    [Google Scholar]
  4. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Molecular and Cellular Biology 5:3403–3409
    [Google Scholar]
  5. Falgout B., Chanock R., Lai C.-J. 1989; Proper processing of dengue virus nonstuctural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. Journal of Virology 63:1852–1860
    [Google Scholar]
  6. Gibson C. A., Schlesinger J. J., Barrett A. D. T. 1988; Prospects for a virus non-structural protein as a vaccine. Vaccine 6:7–9
    [Google Scholar]
  7. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. 1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow 1702 J. R. Putnak and J. J. Schlesingerfever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
    [Google Scholar]
  8. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  9. McCown J., Cochran M., Putnak R., Feighny R., Burrous J., Henchal E., Hoke C. 1990; Protection against lethal Japanese encephalitis with a recombinant baculovirus vaccine. American Journal of Tropical Medicine and Hygiene in press
    [Google Scholar]
  10. Rice C. M., Lenches E. M., Eddy S. R., Shin S. J., Sheets R. L., Strauss J. H. 1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
    [Google Scholar]
  11. Rice C. M., Strauss E. G., Strauss J. H. 1986; Structure of the flavivirus genome. In Togaviruses and Flaviviruses pp 279–327 Schlesinger S., Schlesinger M. Edited by New York: Plenum Press;
    [Google Scholar]
  12. Schlesinger J. J., Brandriss M. W., Monath T. P. 1983; Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology 125:8–17
    [Google Scholar]
  13. Schlesinger J. J., Brandriss M. W., Walsh E. E. 1985; Protection against 17D yellow fever in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. Journal of Immunology 135:2805–2809
    [Google Scholar]
  14. Schlesinger J. J., Brandriss M. W., Cropp C. B., Monath T. P. 1986; Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructual protein NS1. Journal of Virology 60:1153–1155
    [Google Scholar]
  15. Schlesinger J. J., Brandriss M. W., Walsh E. E. 1987; Protection of mice against dengue 2 virus encephalitis by immunization with dengue 2 virus non-structural glycoprotein NS1. Journal of General Virology 68:853–857
    [Google Scholar]
  16. Schlesinger J. J., Brandriss M. W., Walsh E. E., Putnak J. R. 1990; Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. Journal of General Virology 71:593–599
    [Google Scholar]
  17. Theiler M., Smith H. H. 1937; Effect of prolonged cultivation in vitroupon pathogenicity of yellow fever virus. Journal of Experimental Medicine 65:767–786
    [Google Scholar]
  18. Winkler G., Randolph V. B., Cleaves G. R., Ryan T. E., Stollar V. 1988; Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162:187–196
    [Google Scholar]
  19. Zhang Y., Hayes E. P., McCarty E. C., Dubois D. R., Summers P. L., Eckels K. H., Chanock R. M., Lai C. J. 1988; Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology 62:3027–3031
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-8-1697
Loading
/content/journal/jgv/10.1099/0022-1317-71-8-1697
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error